Foghorn Therapeutics Q2 EPS $(0.28) Beats $(0.33) Estimate, Sales $7.557M Beat $6.498M Estimate

Author: Benzinga Newsdesk | August 05, 2025 07:37am
Foghorn Therapeutics (NASDAQ:FHTX) reported quarterly losses of $(0.28) per share which beat the analyst consensus estimate of $(0.33) by 13.85 percent. This is a 37.78 percent increase over losses of $(0.45) per share from the same period last year. The company reported quarterly sales of $7.557 million which beat the analyst consensus estimate of $6.498 million by 16.30 percent. This is a 9.71 percent increase over sales of $6.888 million the same period last year.

Posted In: FHTX